Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca, Docon Technologies collaborate for digitising 1,000 clinics across India

Ruchika Sharma1 July 2021 11:00 AM IST

Bengaluru: AstraZeneca India on Wednesday signed an MoU with Bengaluru-based Docon Technologies for digitising 1,000 clinics across India.Under the...

Covishield to get EMA approval in a month: Serum Institute CEO Adar Poonawalla

Ruchika Sharma1 July 2021 10:00 AM IST

New Delhi: Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in...

Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine

Lupin bags USFDA nod for Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate Tablets under PEPFAR

Ruchika Sharma30 Jun 2021 5:13 PM IST

Mumbai: Global pharma major, Lupin Limited, today announced that the company has received tentative approval from the United States Food and Drug...

Bharat Biotech Covaxin rolling data to start in July: WHO

Ruchika Sharma30 Jun 2021 12:04 PM IST

Hyderabad: Taking the approval process ahead, World Health Organisation (WHO) which is currently approached by Bharat Biotech for an Emergency Use...

Covid-19: 100 million Johnson and Johnson single-shot vaccines likely to be procured from EU for India

Ruchika Sharma30 Jun 2021 11:30 AM IST

Director General, Dr Girdhar Gyani of Association of Healthcare Providers (AHPI) said that JnJ vaccine is likely to cost EUR 5 to 6 (Rs 450 to 550) if...

Covishield marketing authorisation will be considered when application is received: EU agency

Ruchika Sharma29 Jun 2021 5:03 PM IST

New Delhi: The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application...

Moderna seeks CDSCO nod for its Covid-19 vaccine

Ruchika Sharma29 Jun 2021 3:20 PM IST

New Delhi: India''s drug regulator may soon grant restricted emergency use authorisation for Moderna''s COVID-19 vaccine, official sources said on...

Impersonator posing as joint commissioner of Kolkata Municipal Corporation writes to Serum Institute for Covishield, held

Ruchika Sharma29 Jun 2021 2:00 PM IST

Kolkata: Twenty-eight-year-old Debanjan Deb, who was arrested for setting up dubious inoculation camps in the city, claimed during an interrogation...

Johnson and Johnson scraps local trials for its single-shot COVID vaccine in India: Report

Ruchika Sharma29 Jun 2021 1:07 PM IST

New Delhi: Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India and is looking at ways to...

Nosch Labs, CSIR-IICT ink pact for transfer of process knowhow to make anti-Covid drug 2-DG

Ruchika Sharma29 Jun 2021 1:02 PM IST

Hyderabad: CSIR-Indian Institute of Chemical Technology (IICT) and Nosch Labs have entered into a non-exclusive agreement for transfer of the process...

Granules India gets 2 USFDA observations for Chantilly facility

Ruchika Sharma28 Jun 2021 5:36 PM IST

New Delhi: Drug firm Granules India on Monday said the US health regulator has issued two observations after the inspection of the Chantilly facility...

Dr Reddys launches oral anti-COVID drug 2-DG commercially

Ruchika Sharma28 Jun 2021 3:00 PM IST

Hyderabad: Drug major, Dr. Reddy's Laboratories Ltd., today announced the commercial launch of 2-deoxy-D-glucose (2-DG). Dr. Reddy's will supply to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok